Back to search

Article

Induced B-Cell Receptor Diversity Predicts PD-1 Blockade Immunotherapy Response

2024-12-04

Abstract excerpt

<h4>ABSTRACT</h4> Immune checkpoint inhibitors such as anti-PD-1 antibodies (aPD1) can be effective in treating advanced cancers. However, many patients do not respond and the mechanisms underlying these differences remain incompletely understood. In this study, we profile a cohort of patients with locally-advanced or metastatic basal cell carcinoma undergoing aPD-1 therapy using single-cell RNA sequencing, high-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b9d5d415-090b-519a-a17e-7b52e76fa86d
DOI
10.1101/2024.12.03.626669
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Induced B-Cell Receptor Diversity Predicts PD-1 Blockade Immunotherapy ResponseDOI 10.1101/2024.12.03.626669
Select a neighboring publication to make it the new centre.